TherapeuticsMD Inc. (TXMD)
NASDAQ: TXMD
· Real-Time Price · USD
1.17
0.02 (1.72%)
At close: Aug 15, 2025, 3:58 PM
1.18
0.86%
After-hours: Aug 15, 2025, 07:44 PM EDT
TherapeuticsMD Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 6.07M | 5.75M | 5.06M | 5.05M | 5.23M | 4.34M | 4.33M | 10.17M | 13.73M | 17.25M | 38.07M | 27.08M | 26.3M | 30.38M | 65.12M | 104.84M | 111.42M | 137.62M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 14.84M | 15.43M | 16.01M | 16.61M | n/a | 17.86M | 18.48M | 19.07M | 19.79M | 20.27M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 428K | 211K | 130K | 58K | 17.28M | 2.39M | 2.39M | 19.32M | 20.04M | 20.52M | 20.51M | 253K | 254K | 253K | 253K | 253K | 253K | 253K |
Receivables | 3.74M | 3M | 3.56M | 3.32M | 2.91M | 3.22M | 3.09M | 3.13M | 1.04M | 2.04M | n/a | 32.16M | 45.8M | 35.41M | 36.18M | 37.4M | 33.48M | 33.72M |
Inventory | n/a | n/a | n/a | n/a | -168K | n/a | n/a | 632K | 3.4M | n/a | n/a | 6.7M | 6.15M | 8.97M | 7.62M | 7.36M | 7.57M | 7.35M |
Other Current Assets | 3.65M | 3.77M | 3.64M | 3.62M | 3.68M | 1.4M | 1.79M | 3.51M | 1.45M | 3.84M | 16.12M | 19.21M | 19.79M | 8.02M | 7.82M | 6.57M | 6.64M | 6.84M |
Total Current Assets | 13.46M | 12.51M | 12.26M | 12.15M | 11.82M | 9.19M | 9.46M | 17.44M | 19.61M | 24.73M | 55.35M | 87.48M | 98.6M | 84.42M | 119.47M | 159.98M | 159.66M | 187.04M |
Property-Plant & Equipment | 5.73M | 5.95M | 6.1M | 6.3M | 6.5M | 6.69M | 6.87M | 7.07M | 7.27M | 7.46M | 7.66M | 8.3M | 8.62M | 9.16M | 9.43M | 9.78M | 10.48M | 11.02M |
Goodwill & Intangibles | 4.04M | 4.14M | 4.32M | 4.43M | 4.52M | 5.96M | 6.1M | 6.66M | 6.77M | 6.88M | 6.94M | 37.88M | 38.72M | 39.55M | 40.32M | 39.62M | 40.21M | 40.99M |
Total Long-Term Assets | 25.04M | 25.72M | 26.56M | 27.4M | 28.3M | 32.9M | 33.85M | 33.05M | 34.08M | 34.87M | 35.11M | 46.43M | 47.6M | 48.96M | 50M | 49.65M | 50.94M | 52.26M |
Total Assets | 38.5M | 38.24M | 38.82M | 39.55M | 40.13M | 42.09M | 43.31M | 50.49M | 53.69M | 59.6M | 90.46M | 133.91M | 146.2M | 133.38M | 169.47M | 209.63M | 210.6M | 239.31M |
Account Payables | 350K | 176K | 258K | 234K | 143K | 139K | 27K | 696K | 1.51M | 2.33M | 2.16M | 13.38M | 13.98M | 20.75M | 20.32M | 19.59M | 14.56M | 10.31M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.46M | 10.04M | n/a | n/a | n/a | n/a | n/a | 39.59M | n/a | n/a | n/a |
Short-Term Debt | 886K | 1.01M | 1.63M | 1.62M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 93.6M | 90.78M | 202.86M | 188.27M | 15M | 10M | 5M |
Other Current Liabilities | 3.23M | 1.77M | 1.15M | 1.3M | 3.29M | 4.31M | 3.69M | 12.02M | 1.37M | 11.75M | 30.53M | 26.99M | 48.66M | 2.61M | 29.18M | 37.33M | 41.33M | n/a |
Total Current Liabilities | 4.66M | 4.74M | 5.17M | 5.98M | 5.82M | 6.47M | 6.85M | 14.51M | 14.36M | 19.34M | 46.84M | 174.07M | 163.99M | 264.83M | 252.89M | 86.27M | 75.67M | 61.28M |
Long-Term Debt | 5.72M | n/a | n/a | n/a | n/a | n/a | 6.53M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 171.74M | 175.26M | 178.97M |
Other Long-Term Liabilities | 832K | 795K | 744K | 705K | 637K | 637K | 636K | 1.19M | 1.19M | 1.11M | 1.11M | 554K | 554K | 1.23M | 2.14M | 758K | 358K | n/a |
Total Long-Term Liabilities | 6.55M | 6.75M | 6.29M | 6.48M | 6.64M | 6.96M | 7.17M | 7.93M | 8.13M | 8.24M | 8.48M | 8.11M | 8.28M | 9.13M | 10.2M | 180.72M | 184M | 187.5M |
Total Liabilities | 11.21M | 11.5M | 11.45M | 12.46M | 12.46M | 13.42M | 14.02M | 22.44M | 22.49M | 27.58M | 55.31M | 182.18M | 172.27M | 273.96M | 263.09M | 266.99M | 259.68M | 248.78M |
Total Debt | 5.72M | 6.97M | 7.17M | 7.4M | 7.59M | 7.8M | 8.01M | 8.2M | 8.39M | 8.58M | 8.76M | 102.54M | 99.88M | 212.12M | 196.33M | 194.96M | 193.64M | 192.5M |
Common Stock | 11K | 11K | 11K | 11K | 11K | 11K | 11K | 11K | 11K | 10K | 9K | 9K | 9K | 9K | 430K | 425K | 395K | 393K |
Retained Earnings | -951.92M | -952.48M | -951.82M | -952.07M | -951.47M | -950.38M | -949.64M | -948.76M | -945.38M | -942.97M | -939.36M | -1.02B | -988.1M | -1.1B | -1.05B | -1.01B | -960.98M | -918.33M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | -0.00 | 0.00 | n/a | n/a | 0.00 | 0.00 | n/a | n/a | -0.00 | n/a | -2.14M | -1.94M |
Shareholders Equity | 27.29M | 26.74M | 27.37M | 27.09M | 27.67M | 28.66M | 29.29M | 28.05M | 31.2M | 32.02M | 35.14M | -48.27M | -26.07M | -140.58M | -93.62M | -57.36M | -49.07M | -9.48M |
Total Investments | 14.84M | 15.43M | 16.01M | 16.61M | 17.22M | 17.86M | 18.48M | 19.07M | 19.79M | 20.27M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |